Detection of csgA gene in carbapenem-resistant Acinetobacter baumannii strains and targeting with Ocimum sanctum biocompounds

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 184

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-24-5_017

تاریخ نمایه سازی: 18 اردیبهشت 1400

Abstract:

Objective(s): Carbapenem-resistant Acinetobacter baumannii (CRAB) is considered highly virulent due to csgA gene-mediated biofilm formation. The present study aimed to target the same gene, employing the antibiofilm effect of Ocimum sanctum (O. sanctum) essential oil compounds among CRAB strains.Materials and Methods: A semi-quantitative adherent bioassay was performed to detect the biofilm formation in ۷۳ CRAB strains. This was followed by molecular characterization, Polymerase Chain Reaction (PCR) amplification, and csgA gene sequencing. An antibiofilm assay under in vitro conditions, with essential oils of O. sanctum was performed. This was followed with further docking analysis of csgA protein with the selected compounds from the O. sanctum essential oils. A Molinspiration assessment was also done to elicit the drug likeliness of the biocompounds.Results: The biofilm assay showed ۵۸.۹% as high-grade and ۳۱.۵% as low-grade biofilm formers, while ۹.۵۸% were non-biofilm formers. Molecular characterization of the csgA gene showed ۲۰.۵۴% (۱۵/۷۳) positivity. The strains that were imipenem resistant also showed the csgA gene to be present (۱۰۰%; ۱۵/۱۵), with ۶۰% (۹/۱۵) and ۲۰% (۳/۱۵) for meropenem and doripenem resistance respectively. A crystal violet assay for determining cell viability was done in vitro, which gave Minimum biofilm inhibition concentrations of ۵۰% (MBEC۵۰) at ۲۵ µl and ۹۰% (MBEC۹۰) at ۵۰ µl. The docking analysis done in silico showed benzofuran to possess the lowest binding energy and highest hydrogen bond interactions. Conclusion: The results indicate benzofuran, from the O. sanctum essential oils, to be effective in targeting the csgA gene among CRAB strains. Additionally, validation of these findings through in vivo studies is required.

Authors

Saishree Anchana R

Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, P.H.Road, Chennai, Tamilnadu - ۶۰۰۰۷۷, India

Smiline Girija A.S

Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, P.H.Road, Chennai, Tamilnadu - ۶۰۰۰۷۷, India

Shoba Gunasekaran

Department of Biotechnology, DG Vaishnav College, Arumbakkam, Chennai – ۶۰۰ ۱۰۶

Vijayashree Priyadharsini J

Department of Microbiology & Blue Lab, [Instead of BRULAC-DRC] Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, P.H.Road, Chennai, Tamilnadu - ۶۰۰۰۷۷, India

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1. Gonzalez-Villoria AM, Valverde-Garduno V. Antibiotic-resistant Acinetobacter baumannii increasing success ...
  • 2. Wang X, Qin LJ. A review on Acinetobacter baumannii. ...
  • 3. Dijkshoorn L, Nemec A, Seifert H. An increasing threat ...
  • 4. McConnell MJ, Pérez-Ordóñez A, Pérez-Romero P, Valencia R, Lepe ...
  • 6. Priyadharsini JV, Girija AS, Paramasivam A. An insight into ...
  • 7. Smiline Girija AS. CLSI based antibiogram profile and the ...
  • 8. Blanco N, Harris AD, Rock C, Johnson JK, Pineles ...
  • 9. Akrami F, Namvar AE. Acinetobacter baumannii as nosocomial pathogenic ...
  • 10. Kikuchi T, Mizunoe Y, Takade A, Naito S, Yoshida ...
  • 11. Saleem HG, Seers CA, Sabri AN, Reynolds EC. Dental ...
  • 12. DeBenedictis EP, Ma D, Keten S. Structural predictions for ...
  • 13. Wu L, Wu L, Wang T, Zou Z, Jiang ...
  • 14. Bian Z, Brauner A, Li Y, Normark S. Expression ...
  • 15. Hammar MR, Arnqvist A, Bian Z, Olsén A, Normark ...
  • 16. Kwon SO, Gho YS, Lee JC, Kim SI. Proteome ...
  • 17. De Gregorio E, Roscetto E, Iula VD, Martinucci M, ...
  • 18. Cevahir N, Demir M, Kaleli I, Gurbuz M, Tikvesli ...
  • 19. Perov S, Lidor O, Salinas N, Golan N, Tayeb-Fligelman ...
  • 20. Robinson LS, Ashman EM, Hultgren SJ, Chapman MR. Secretion ...
  • 21. Obara H, Aikawa N, Hasegawa N, Hori S, Ikeda ...
  • 22. Thummeepak R, Kongthai P, Leungtongkam U, Sitthisak S. Distribution ...
  • 23. Baliga MS, Jimmy R, Thilakchand KR, Sunitha V, Bhat ...
  • 24. Zheljazkov VD, Cantrell CL, Tekwani B, Khan SI. Content, ...
  • 25. Bhattacharyya P, Bishayee A. Ocimum sanctum Linn.(tulsi): an ethnomedicinal ...
  • 26. Kouidhi B, Zmantar T, Hentati H, Bakhrouf A. Cell ...
  • 27. Avila-Novoa MG, Solís-Velázquez OA, Rangel-Lopez DE, González-Gómez JP, Guerrero-Medina ...
  • 28. Girija AS S, Priyadharsini J V. Prevalence of Acb ...
  • 29. Smiline Girija AS, Vijayashree Priyadharsini J, Arumugam P. CLSI ...
  • 30. Zeighami H, Valadkhani F, Shapouri R, Samadi E, Haghi ...
  • 31. Stauder M, Papetti A, Mascherpa D, Schito AM, Gazzani ...
  • 32. Preuss HG, Echard B, Enig M, Brook I, Elliott ...
  • 33.Tariq M, Sirajuddin M, Ali S, Khalid N, Tahir MN, ...
  • 34. Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug ...
  • 35. Vanommeslaeghe K, Hatcher E, Acharya C, Kundu S, Zhong ...
  • 36. Watnick P, Kolter R. Biofilm, city of microbes. J ...
  • 37. Espinal P, Marti S, Vila J. Effect of biofilm ...
  • 38. Lin LT, Hsu WC, Lin CC. Antiviral natural products ...
  • 39. Davis JS, McMillan M, Swaminathan A, Kelly JA, Piera ...
  • 40. Gualdi L, Tagliabue L, Landini P. Biofilm formation-gene expression ...
  • 41. Al-Kadmy IM, Ali AN, Salman IM, Khazaal SS. Molecular ...
  • 42. Choudhury SS, Bashyam L, Manthapuram N, Bitla P, Kollipara ...
  • 43. Lee JS, Choi CH, Kim JW, Lee JC. Acinetobacter ...
  • 44. Choi CH, Lee EY, Lee YC, Park TI, Kim ...
  • 45. Kalaivani R, Devi VJ, Umarani R, Periyanayagam K, Kumaraguru ...
  • 46. Mirdha BR, Naik SN, Mahapatra SC. Antimicrobial activities of ...
  • 47. Dey R, De K, Mukherjee R, Ghosh S, Haldar ...
  • 48. Burton E, Yakandawala N, LoVetri K, Madhyastha MS. A ...
  • 49. Amin MN, Dewan SM, Noor W, Shahid-Ud-Daula AF. Characterization ...
  • 50. Hussain EH, Jamil K, Rao M. Hypoglycaemic, hypolipidemic and ...
  • 51. Rao YS, Kotakadi VS, Prasad TN, Reddy AV, Gopal ...
  • 52. Jiang X, Liu W, Zhang W, Jiang F, Gao ...
  • 53. Barboza JN, da Silva Maia Bezerra Filho C, Silva ...
  • 54. Kenchappa R, Bodke YD, Asha B, Telkar S, Sindhe ...
  • 55. Zhao Y, Sanner MF. FLIPDock: docking flexible ligands into ...
  • 56. Dhara L, Tripathi A. Antimicrobial activity of eugenol and ...
  • 57. Hou T, Wang J, Zhang W, Xu X. ADME ...
  • نمایش کامل مراجع